ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Bluesight Streamlines B2B Integration with Platform Consolidation and Cleo’s Blended Services

Medication tracking software provider achieves increased efficiency by replacing multiple in-house integration solutions and EDI vendors with Cleo Integration Cloud and tapping into Cleo’s Managed Services expertise

Established in 2011, Bluesight provides simple medication tracking from purchase to patient administration, for customers including hospital pharmacists, diversion specialists, and pharmacy supply chain organizations. The software development company relies on robust integration software to process large EDI files and millions of transactions annually.

As Bluesight’s business evolved over the past dozen or so years, it became clear that its B2B supply chain integration strategy needed to be revisited. The original combination of multiple in-house integration solutions and reliance on various EDI vendors resulted in a costly and overly complex integration configuration, lengthy and problematic trading partner onboarding times, and poor visibility. This hindered Bluesight’s ability to scale its business.

To ensure Bluesight’s operations could keep up with business growth, the software development company replaced its in-house solutions and EDI vendors with one platform that could accommodate all its needs, now and well into the future -- Cleo Integration Cloud (CIC). Additionally, Bluesight turned to and continues to utilize Cleo’s blended services approach, which is a custom Managed Services option where integration responsibilities are split between Bluesight and Cleo’s team of experts.

By migrating to CIC and utilizing Cleo’s blended services approach, Bluesight discovered and created value through numerous straightforward integration improvements, including:

  • Platform consolidation—EDI and API combined into one, easy-to-use solution
  • Increased internal bandwidth—Cleo’s blended services approach frees Bluesight to concentrate on developing innovative products
  • Fast trading partner onboarding—leading to accelerated sales cycles, faster time-to-revenue, and more satisfied customers
  • Scalability—reliable processing for large files and a high volume of transactions
  • Trustworthy protocol and standards support—connect with any trading partner
  • In-depth visibility—drill down into transactions, integrations, processes, and errors, with all integration data available in a centralized dashboard

Bluesight’s Technical Program Manager, Ravi Boppana says, “By offloading EDI processing to Cleo, now we can seamlessly manage the high transaction volumes that our business requires. This allowed us to shift our efforts from the complexities of integration to supporting our company’s core business focus: developing exceptional Bluesight products that transform the world of medicine.”

View the complete Bluesight Case Study here.

About Bluesight

Bluesight simplifies medication tracking from purchase to patient administration. With a suite of Medication Intelligence™ solutions, Bluesight enables hospitals and health systems to worry less about inventory, compliance and costs and focus on what matters most: patient care. More than 2,200 United States and Canadian hospitals depend on Bluesight every day to optimize pharmacy operations, prevent risk and noncompliance and improve financial health. For more information, please visit Bluesight’s website.

About Cleo

Cleo is an ecosystem integration software company focused on business outcomes, ensuring each customer’s potential is realized by delivering solutions that make it easy to discover and create value through the movement and integration of B2B enterprise data. Cleo gives customers strategic, “outside-in” visibility into the critical end-to-end business flows happening across their ecosystems of partners and customers, marketplaces, and internal cloud and on-premise applications. Our solutions empower teams to drive business agility, accelerate onboarding, facilitate the modernization of key business processes, and capture new revenue streams by reimagining and remastering their digital ecosystem through robust application, B2B, and data integration technologies. For more information, visit www.cleo.com or call +1.815.282.7695.

Contacts

Media Contact

Kathleen See

10Fold Communications on behalf of Cleo

cleo@10fold.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.